Why Diligence Matters: Don’t Buy Acadia Healthcare’s Roll-Up
We put behavioral healthcare provider Acadia Healthcare (ACHC) in the Danger Zone just over a year ago and despite the company touting its impressive non-GAAP numbers, the stock is just as dangerous as ever.
Sam McBride